Exobiosphere, a Luxembourg-based space biotech startup, has secured €1 million in non-dilutive funding through the Jeune Entreprise Innovante (JEI) aid scheme. This grant will fuel the company's commercial expansion, scale its orbital high-throughput screening platform capable of over 2,000 simultaneous automated experiments, and strengthen its team to serve more pharmaceutical and biotech partners globally. The funding, administered by the Ministry of the Economy, supports Exobiosphere's mission to accelerate drug discovery and biomedical research in microgravity.
